Aggelos Rigopoulos CARDIOLOGIST CLINICAL Associate Director, Cardiology Department, MITERA Hospital

• 2003: PhD-thesis entitled “ Subclinical skeletal myopathy in hypertrophic cardiomyopathy and its relation with clinical characteristics of the disease” – grade “excellent” – Department of Cardiology, School of Medicine, University of Athens, Greece.

• Fellow of the European Society of Cardiology (FESC)
• Hellenic Society of Cardiology
• German Cardiac Society (Deutsche Gesellschaft für Kardiologie, DGK)
• European Association of Percutaneous Cardiovascular Interventions (EAPCI)
• ESC Heart Failure Association (HFA)
• ESC Acute Cardiovascular Care Association (ACCA)
• ESC WG on Myocardial and Pericardial Diseases – Nucleus Secretary 2014-2018
• Hellenic Society of Lipidology and Atherosclerosis

Editorial Boards

• ESC Heart Failure IF 3,902
• BMC Cardiovascular Disorders IF 2,078
• Cells (Topics Board) IF 4,366
• Hearts

AD-HOC REVIEWER for peer-reviewed international journals

• Journal of the American College of Cardiology
• Circulation Cardiovascular Interventions
• Circulation Cardiovascular Imaging
• International Journal of Cardiology
• Catheterization and Cardiovascular Interventions
• European Journal of Heart Failure
• Current Cardiology Reviews
• BMC Cardiovascular Disorders
• Heart Failure Reviews
• Cardiology
• Heart Lung and Circulation
• Hellenic Journal of Cardiology
• Herz
• Southern Medical Journal
• Interventional Cardiology
• Biomarkers in Medicine
• Case Reports in Cardiology
• Arrhythmia and Electrophysiology Reviews

• 2017–2020 Consultant Cardiologist (Oberarzt Kardiologie), Head of Cardiac Catheterization Laboratory, Innere Medizin III, Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle, Halle, Germany
• 2012–2017 Consultant Cardiologist (Oberarzt Kardiologie), Head of Cardiac Catheterization Laboratory, Medizinische Klinik I, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany
• 2004-2011 Consultant Cardiologist, 2^nd Department of Cardiology, University of Athens Medical School, Attikon University Hospital
• 2002  Training Fellowship (Scholarship from Hellenic Cardiological Society and Hellenic Heart Foundation) in Leopoldina Krankenhaus, Schweinfurt, Germany (Main subject: Interventional treatment of hypertrophic obstructive cardiomyopathy)
• 1998-2004  Clinical & Research Fellow, Catheterization Laboratory Department of Cardiology, University of Athens Medical School, Hippocration Hospital Athens
• 1998-2004  Clinical & Research Fellow, Pheidippides Project, Division of Inherited Cardiovascular Diseases, Department of Cardiology, University of Athens Medical School, Hippocration Hospital
• 1999-2000 On-call cardiologist, Intensive care unit, Athens Medical Centre, Palaio Faliro Clinic

Clinical Interest:

• Cardiac catheterization – Coronary angiography
• Complex coronary intervention (a.o. bifurcation-PCI, left main stenoses)
• Intracoronary imaging with intravascular ultrasound (IVUS) and optical coherence tomography (OCT)
• Impella-supported PCI, cardiogenic shock
• Right heart catheterization
• Alcohol septal ablation (ASA) in hypertrophic obstructive cardiomyopathy (HOCM)
• Transcatheter valve interventions
• LAA-occluder implantation
• PFO-occluder implantation

Research Interest: 

• Interventional cardiology
• Cardiomyopathies
• Heart failure
• Cell protection in ischaemia and hypertrophy

• 1999 Best Oral Abstract presentation in 20th Panhellenic Cardiology Congress, Herakleion Crete (1999).
  Ν.Ι. Protonotarios, Α.Α. Tsatsopoulou, Α.Ν. Anastasakis, Α.G. Rigopoulos, Α.Μ. Theopistou, E.L. Sevdalis, Ε. Karvouni, C.Ι. Stefanadis, P.Κ. Toutouzas. The natural course and prognosis of arrhythmogenic right ventricular cardiomyopathy in Naxos disease.
• 2007 Best Poster Abstract presentation «Hans-Jürgen-Bretschneider-Posterpreis» in 31. Herbsttagung der Deutschen Gesellschaft für Kardiologie (31st Autumn Congress of German Cardiac Society), Kologne, 2007. Β. Pfeiffer, A. Neugebauer, C. Blank, P. Ziemssen, A. Rigopoulos, H. Seggewiss. Therapiestratefizierung bei jungen Patienten mit hypertropher Kardiomyopathie (Stratification of therapy in young patients with hypertrophic cardiomyopathy)
• 2009 Best Poster Abstract presentation in 3rd Panhellenic Congress of Medical Biochemistry, Athens, 2009. Β. Salpeas, Ε. Faviou, Ε. Sakadakis, Α.S. Kalogeropoulos, Α.G. Rigopoulos, Α. Triantafyllis, Ι. Rizos, Ε. Patsouris, D. Kremastinos. Aging and nuclear Farnesoid-X-receptor in the SHR animal model: Control and reshaping of molecular pathways of metabolic substrates usage, inflammatory disorders and survival.
• 2009 Distinction in 3rd Panhellenic Congress of Medical Biochemistry, Athens, 2009. Ε. Faviou, Ε. Sakadakis, Α.S. Kalogeropoulos, Α.G. Rigopoulos, Α. Triantafyllis, Ε. Voltyrakis, S. Papathanasiou, Τ. Papanikolaou, Ι. Rizos, D.T.  Kremastinos. Association of metalloproteinases and atrial fibrillation in hypertensive patients.
• 2019  First Prize in Cardiology, BMA Medical Book Awards 2019 for The ESC Textbook of Cardiovascular Medicine, 3^rd Edition and ESC CardioMed

Book Chapters

• Hubert Seggewiss, Angelika Batzner, Angelos G. Rigopoulos
  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
  In: Percutaneous interventional cardiovascular medicine – The PCR-EAPCI Textbook. Europa Edition 2019, (Update)
• Angelos G. Rigopoulos, Hubert Seggewiss
  Pericardial masses and congenital abnormalities
  In: The ESC Textbook of Cardiovascular Medicine, 3^rd Edition, ISBN 978-0-19-878490-6
• Hubert Seggewiss, Angelos G. Rigopoulos
  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
  Ιn: Percutaneous interventional cardiovascular medicine – The PCR-EAPCI Textbook. Europa Edition 2015, (Update)
• Hubert Seggewiss, Angelos G. Rigopoulos
  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
  In: Percutaneous interventional cardiovascular medicine – The PCR-EAPCI Textbook. Europa Edition 2012, pp. 461-476 & Update 2015
• Hubert Seggewiss, Barbara Pfeiffer, Angelos Rigopoulos
  Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy: Feasibility, safety and long-term results
   In European Conference on Myocardial and Pericardial Disease: The First 50 Years of Cardiomyopathies, Belgrade, Serbia, 2009, pp.71
• Angelos G. Rigopoulos
  Classification of cardiomyopathies
  Cardiology (Textbook), Ed. D.T. Kremastinos, Paschalidis Editions 2009, Athens, Vol. ΙΙ, pp. 1163-1166
• ISBN 978-960-399-764-1
• Angelos G. Rigopoulos
  Hypertrophic cardiomyopathy: Advances in genetic aetiology and treatment
  Cardiology (Textbook), Ed. D.T. Kremastinos, Paschalidis Editions 2009, Athens, Vol. ΙΙ, pp. 1167-1192
• ISBN 978-960-399-764-1
• Angelos G. Rigopoulos, Aias Antoniadis
  Primary coronary angioplasty in acute myocardial infarction with ST segment elevation
  Cardiology (Textbook), Ed. D.T. Kremastinos, Paschalidis Editions 2009, Athens, Vol. ΙΙ, pp. 1359-1382
• ISBN 978-960-399-764-1
• Angelos G. Rigopoulos
  The role of echocardiography in hypertrophic cardiomyopathy and septal myocardial ablation
  Echocardiographic Issues in Cardiovascular Diseases,  Ed. Ι. Ν. Vlasseros, Athens 2008
• Hubert Seggewiss, Angelos Rigopoulos, Lothar Faber, Peer Ziemssen
  Alcohol septal ablation
  In Barry Maron, Ed. Diagnosis and Management of Hypertrophic Cardiomyopathy. Blackwell Futura 2004, pp. 259-278
• ISBN 978-1-4051-1732-6

Total number of publications in peer- reviewed journals: 85

• Mizia-Stec K, Caforio ALP, Charron P, Gimeno JR, Elliott P, Kaski JP, Maggioni AP, Tavazzi L, Rigopoulos AG, Laroche C, Frigy A, Zachara E, Pena-Pena ML, Olusegun-Joseph A, Pinto Y, Sala S, Drago F, Blagova O, Reznik E, Tendera M.
  Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology.
  ESC Heart Fail. 2020 Sep 17. doi: 10.1002/ehf2.12854. Epub ahead of print. PMID: 32940421.
• Stähli BE, Varbella F, Schwarz B, Nordbeck P, Felix SB, Lang IM, Toma A, Moccetti M, Valina C, Vercellino M, Rigopoulos AG, Rohla M, Schindler M, Wischnewsky M, Linke A, Schulze PC, Richardt G, Laugwitz KL, Weidinger F, Rottbauer W, Achenbach S, Huber K, Neumann FJ, Kastrati A, Ford I, Ruschitzka F, Maier W; MULTISTARS AMI Investigators.
  Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
  Am Heart J. 2020 Oct;228:98-108. PMID: 32871329
• Noutsias M, Melnyk H, Ali M, Daehnert I, Empen K, Sedding D, Rigopoulos AG.
  Dual device closure of a bilobar left atrial appendage with a plug (Watchman 2.5™ 30 mm) and a pacifier (Amulet™ 20 mm) device.
  Hellenic J Cardiol. 2020 Apr 15:S1109-9666(20)30070-1. doi: 10.1016/j.hjc.2020.03.005. Epub ahead of print. PMID: 32304818.
• Rigopoulos AG, Klutt B, Matiakis M, Apostolou A, Mavrogeni S, Noutsias M. Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy.
  Viruses. 2019 Jun 18;11(6):566. doi: 10.3390/v11060566. PMID: 31216741; PMCID: PMC6631559.
• Rigopoulos AG, Ali M, Abate E, Torky AR, Matiakis M, Mammadov M, Melnyk H, Vogt A, de Vecchis R, Bigalke B, Wohlgemuth W, Mavrogeni S, Noutsias M.
  Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
  Heart Fail Rev. 2019 Jul;24(4):521-533. doi: 10.1007/s10741-019-09776-3. PMID: 30790171.
• Rigopoulos AG, Panou F, Sakadakis E, Frogoudaki A, Papadopoulou K, Triantafyllidi H, Ali M, Iliodromitis E, Rizos I, Noutsias M.
  Cardiopulmonary Exercise Test Parameters at Three Months After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy Are Associated With Late Clinical Outcome.
  Heart Lung Circ. 2020 Feb;29(2):202-210. doi: 10.1016/j.hlc.2018.12.007. Epub 2019 Jan 22. PMID: 30773321.
• Rigopoulos AG, Ali M, Abate E, Matiakis M, Melnyk H, Mavrogeni S, Leftheriotis D, Bigalke B, Noutsias M.
  Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy.
  Heart Fail Rev. 2019 May;24(3):359-366. PMID: 30617667.
• Rigopoulos AG, Sakellaropoulos S, Ali M, Mavrogeni S, Manginas A, Pauschinger M, Noutsias M.
  Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.
  Heart Fail Rev. 2018 Nov;23(6):907-917. PMID: 29736811.
• Rigopoulos AG, Daci S, Pfeiffer B, Papadopoulou K, Neugebauer A, Seggewiss H. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
  Clin Res Cardiol. 2016 Nov;105(11):953-961. PMID: 27270758
• Rigopoulos AG, Seggewiss H. Hypertrophic cardiomyopathy.
  Lancet. 2013 Apr 27;381(9876):1456. PMID: 23622277.